Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,983,857
+$752,285 QoQ
Shares Held
1,654
+23.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,510
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026National Philanthropic Trust holds $15,575,343 across 9 Drug Manufacturers - General names. LLY ranks #3 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,110 | $6,631,156 | |
| 2 | MRK |
Merck & Co., Inc.
|
18,602 | $2,390,357 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,654 | $1,983,857 | |
| 4 | ABBV |
AbbVie Inc.
|
7,742 | $1,948,196 | |
| 5 | NVO |
Novo Nordisk A S
|
17,646 | $845,949 | |
| 6 | AMGN |
Amgen Inc
|
1,479 | $535,575 | |
| 7 | AZN |
Astrazeneca PLC
|
2,734 | $518,421 | |
| 8 | NVS |
Novartis AG
|
2,896 | $453,861 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,983,857 | 1,654 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,231,572 | 1,339 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,505,626 | 1,401 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $1,158,997 | 1,519 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $752,246 | 965 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,075,334 | 1,302 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $765,052 | 991 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $568,773 | 642 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $665,454 | 735 | Shares | Sole | 2026-05-15 | |
| 2024-03-31 | $697,052 | 896 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $907,023 | 1,556 | Shares | Sole | 2026-06-12 | |
| No filing history on record for this holder in this stock. | ||||||